Skip to main content
Atea Pharmaceuticals, Inc. (AVIR)
NASDAQ: AVIR · Real-Time Price · USD
4.300
+0.090 (2.14%)
At close: Nov 13, 2026, 4:00 PM EST
4.360
+0.060 (1.40%)
After-hours: Nov 13, 2026, 7:25 PM EST

Atea Pharmaceuticals Revenue

Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
55
Market Cap
345.31M

Revenue Chart

Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025---
Dec 31, 2024---
Dec 31, 2023---
Dec 31, 2022---
Dec 31, 2021351.37M302.73M622.49%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.

Related Stocks

Company NameRevenue
Autolus Therapeutics137.43M
Agenus133.95M
Enanta Pharmaceuticals65.26M
Precision BioSciences45.04M
X4 Pharmaceuticals16.96M
ProKidney818.00K
Inhibikase Therapeutics1.00
Revenue Rankings

AVIR News

More News